A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study.

Gavin GiovannoniAlexey BoykoJorge CorrealeGilles EdanMark S FreedmanXavier MontalbanKottil RammohanDusan StefoskiBassem YamoutThomas LeistAida AydemirLaszlo BorsiElisabetta Verdun di Cantogno

Published in: Neurodegenerative disease management (2023)

: NCT03961204 (CLASSIC-MS) (ClinicalTrials.gov).

Keyphrases

multiple sclerosis
white matter
mass spectrometry
randomized controlled trial
ms ms
autism spectrum disorder
systemic lupus erythematosus